Johnson & Johnson (JNJ) said late Monday that the US Bankruptcy Court for the Southern District of Texas denied its subsidiary Red River Talc's request to confirm its proposed prepackaged bankruptcy plan.
The drugmaker said it plans to return to the tort system to challenge and defeat meritless talc claims instead of pursuing an appeal.
J&J has no intention of settling or paying plaintiffs' lawyers, the company said, adding it will reverse about $7 billion of its previous reserve related to the litigation.
"As we have repeatedly stated, in the absence of plan confirmation, we will vigorously present our case in the tort system, starting with the adjudication of the motions pending in the Multi-District Litigation to exclude plaintiffs' experts and to disqualify the lead counsel for its unethical breaches," the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.